Intelgenx Technologies Corp (IGXT)
0.1639
-0.01
(-3.53%)
USD |
OTCM |
Apr 23, 15:57
Intelgenx Technologies Cash from Operations (TTM): -6.525M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.525M |
| September 30, 2023 | -8.552M |
| June 30, 2023 | -9.205M |
| March 31, 2023 | -9.491M |
| December 31, 2022 | -9.516M |
| September 30, 2022 | -9.043M |
| June 30, 2022 | -8.687M |
| March 31, 2022 | -7.991M |
| December 31, 2021 | -7.173M |
| September 30, 2021 | -5.604M |
| June 30, 2021 | -5.43M |
| March 31, 2021 | -5.069M |
| December 31, 2020 | -5.768M |
| September 30, 2020 | -7.348M |
| June 30, 2020 | -7.21M |
| March 31, 2020 | -7.974M |
| December 31, 2019 | -8.199M |
| September 30, 2019 | -8.498M |
| June 30, 2019 | -9.526M |
| March 31, 2019 | -8.732M |
| December 31, 2018 | -8.53M |
| September 30, 2018 | -7.982M |
| June 30, 2018 | -6.121M |
| March 31, 2018 | -6.051M |
| December 31, 2017 | -4.383M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.826M |
| June 30, 2017 | 1.424M |
| March 31, 2017 | 2.262M |
| December 31, 2016 | 1.729M |
| September 30, 2016 | 3.066M |
| June 30, 2016 | -0.633M |
| March 31, 2016 | -0.231M |
| December 31, 2015 | 0.546M |
| September 30, 2015 | 0.793M |
| June 30, 2015 | -0.653M |
| March 31, 2015 | -1.071M |
| December 31, 2014 | -1.38M |
| September 30, 2014 | -2.127M |
| June 30, 2014 | -2.065M |
| March 31, 2014 | -1.771M |
| December 31, 2013 | -1.173M |
| September 30, 2013 | -1.419M |
| June 30, 2013 | -1.488M |
| March 31, 2013 | -2.051M |
| December 31, 2012 | -1.638M |
| September 30, 2012 | -1.713M |
| June 30, 2012 | -1.767M |
| March 31, 2012 | -1.181M |
| December 31, 2011 | -2.316M |
| September 30, 2011 | -2.194M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.526M
Minimum
Jun 2019
-5.069M
Maximum
Mar 2021
-7.727M
Average
-7.991M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |